{"id":"https://openalex.org/W2135873661","doi":"https://doi.org/10.1016/j.cmpb.2016.02.001","title":"PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studies","display_name":"PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studies","publication_year":2016,"publication_date":"2016-02-08","ids":{"openalex":"https://openalex.org/W2135873661","doi":"https://doi.org/10.1016/j.cmpb.2016.02.001","mag":"2135873661","pmid":"https://pubmed.ncbi.nlm.nih.gov/27000295"},"language":"en","primary_location":{"id":"doi:10.1016/j.cmpb.2016.02.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cmpb.2016.02.001","pdf_url":null,"source":{"id":"https://openalex.org/S138959710","display_name":"Computer Methods and Programs in Biomedicine","issn_l":"0169-2607","issn":["0169-2607","1872-7565"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computer Methods and Programs in Biomedicine","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-253304","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081380130","display_name":"Yasunori Aoki","orcid":"https://orcid.org/0000-0002-5881-2023"},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yasunori Aoki","raw_affiliation_strings":["Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden. Electronic address: yaoki@uwaterloo.ca","Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden"],"affiliations":[{"raw_affiliation_string":"Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden. Electronic address: yaoki@uwaterloo.ca","institution_ids":[]},{"raw_affiliation_string":"Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078709193","display_name":"Monika Sundqvist","orcid":null},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["GB","SE"],"is_corresponding":false,"raw_author_name":"Monika Sundqvist","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden","Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden#TAB#"],"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden#TAB#","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033093691","display_name":"Andrew C. Hooker","orcid":"https://orcid.org/0000-0002-2676-5912"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew C. Hooker","raw_affiliation_strings":["Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden"],"affiliations":[{"raw_affiliation_string":"Pharmacometrics Research Group, Dept. Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002506738","display_name":"Peter Gennemark","orcid":"https://orcid.org/0000-0002-7865-7454"},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["GB","SE"],"is_corresponding":false,"raw_author_name":"Peter Gennemark","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden","Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden#TAB#"],"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden#TAB#","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5081380130"],"corresponding_institution_ids":[],"apc_list":{"value":2880,"currency":"USD","value_usd":2880},"apc_paid":null,"fwci":0.3593,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.64328257,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"127","issue":null,"first_page":"126","last_page":"143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10848","display_name":"Advanced Multi-Objective Optimization Algorithms","score":0.9927999973297119,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10848","display_name":"Advanced Multi-Objective Optimization Algorithms","score":0.9927999973297119,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10621","display_name":"Gene Regulatory Network Analysis","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.988099992275238,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.7614253759384155},{"id":"https://openalex.org/keywords/software","display_name":"Software","score":0.5547891855239868},{"id":"https://openalex.org/keywords/software-design","display_name":"Software design","score":0.5378856062889099},{"id":"https://openalex.org/keywords/design-of-experiments","display_name":"Design of experiments","score":0.48304563760757446},{"id":"https://openalex.org/keywords/optimal-design","display_name":"Optimal design","score":0.459655225276947},{"id":"https://openalex.org/keywords/reliability-engineering","display_name":"Reliability engineering","score":0.35407114028930664},{"id":"https://openalex.org/keywords/software-engineering","display_name":"Software engineering","score":0.33111679553985596},{"id":"https://openalex.org/keywords/software-development","display_name":"Software development","score":0.25082820653915405},{"id":"https://openalex.org/keywords/machine-learning","display_name":"Machine learning","score":0.14302301406860352},{"id":"https://openalex.org/keywords/programming-language","display_name":"Programming language","score":0.139914870262146},{"id":"https://openalex.org/keywords/engineering","display_name":"Engineering","score":0.08728891611099243}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.7614253759384155},{"id":"https://openalex.org/C2777904410","wikidata":"https://www.wikidata.org/wiki/Q7397","display_name":"Software","level":2,"score":0.5547891855239868},{"id":"https://openalex.org/C52913732","wikidata":"https://www.wikidata.org/wiki/Q857102","display_name":"Software design","level":4,"score":0.5378856062889099},{"id":"https://openalex.org/C34559072","wikidata":"https://www.wikidata.org/wiki/Q2334061","display_name":"Design of experiments","level":2,"score":0.48304563760757446},{"id":"https://openalex.org/C186394612","wikidata":"https://www.wikidata.org/wiki/Q7098942","display_name":"Optimal design","level":2,"score":0.459655225276947},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.35407114028930664},{"id":"https://openalex.org/C115903868","wikidata":"https://www.wikidata.org/wiki/Q80993","display_name":"Software engineering","level":1,"score":0.33111679553985596},{"id":"https://openalex.org/C529173508","wikidata":"https://www.wikidata.org/wiki/Q638608","display_name":"Software development","level":3,"score":0.25082820653915405},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.14302301406860352},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.139914870262146},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.08728891611099243},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D010600","descriptor_name":"Pharmacology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010600","descriptor_name":"Pharmacology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010600","descriptor_name":"Pharmacology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.cmpb.2016.02.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cmpb.2016.02.001","pdf_url":null,"source":{"id":"https://openalex.org/S138959710","display_name":"Computer Methods and Programs in Biomedicine","issn_l":"0169-2607","issn":["0169-2607","1872-7565"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computer Methods and Programs in Biomedicine","raw_type":"journal-article"},{"id":"pmid:27000295","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27000295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computer methods and programs in biomedicine","raw_type":null},{"id":"pmh:oai:DiVA.org:uu-253304","is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-253304","pdf_url":null,"source":{"id":"https://openalex.org/S4306401559","display_name":"KTH Publication Database DiVA (KTH Royal Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Manuscript (preprint)"}],"best_oa_location":{"id":"pmh:oai:DiVA.org:uu-253304","is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-253304","pdf_url":null,"source":{"id":"https://openalex.org/S4306401559","display_name":"KTH Publication Database DiVA (KTH Royal Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Manuscript (preprint)"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5699999928474426}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W179749608","https://openalex.org/W241221881","https://openalex.org/W1515666340","https://openalex.org/W1541421582","https://openalex.org/W1542069658","https://openalex.org/W1834879878","https://openalex.org/W1968663826","https://openalex.org/W1968678821","https://openalex.org/W1975404751","https://openalex.org/W1975521766","https://openalex.org/W2020320358","https://openalex.org/W2021612332","https://openalex.org/W2027529221","https://openalex.org/W2036105991","https://openalex.org/W2043858875","https://openalex.org/W2043976500","https://openalex.org/W2049797245","https://openalex.org/W2068576766","https://openalex.org/W2098168282","https://openalex.org/W2100963673","https://openalex.org/W2102739590","https://openalex.org/W2126820341","https://openalex.org/W2142503533","https://openalex.org/W2144578442","https://openalex.org/W2167646568","https://openalex.org/W2171238253","https://openalex.org/W2582743722","https://openalex.org/W3097925195","https://openalex.org/W3103871524","https://openalex.org/W3106346928","https://openalex.org/W6609241794","https://openalex.org/W6632444075"],"related_works":["https://openalex.org/W2262437913","https://openalex.org/W38003520","https://openalex.org/W2918335920","https://openalex.org/W2316484965","https://openalex.org/W3184080862","https://openalex.org/W2082729972","https://openalex.org/W2001176540","https://openalex.org/W3109596955","https://openalex.org/W2295180988","https://openalex.org/W2419141552"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-04-05T17:49:38.594831","created_date":"2025-10-10T00:00:00"}